Tourette syndrome: Update and review of the literature

Neurologist

Volumn 4, Issue 4, 1998, Pages 188-195

  Feigin, Andrew ^a,b   Clarke, Hillary ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

ADHD; OCD; Review; Tourette syndrome

Indexed keywords

BOTULINUM TOXIN; CLONIDINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; HOMOVANILLIC ACID; LAMOTRIGINE; METHYLPHENIDATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; PAROXETINE; PEMOLINE; PIMOZIDE; PSYCHOSTIMULANT AGENT; RACLOPRIDE; RILUZOLE; RISPERIDONE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; UNINDEXED DRUG;

ATTENTION DEFICIT DISORDER; BASAL GANGLION; DIFFERENTIAL DIAGNOSIS; GENETICS; GILLES DE LA TOURETTE SYNDROME; HUMAN; OBSESSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMOCORTICAL TRACT; TIC;

EID: 0031848238     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-199807000-00003     Document Type: Review

References (105)

1. Itard JMG. Mémoire sur quelques fonctions involontaires des appareils de la locomotion de la préhension et de la voix. Arch Gen Med 1825;8:385-407.
2. Gilles de la Tourette G. Etude sur une affection nerveuse caracterisee par de l'incoordination motrice accompagnee d'echolalie et de copralalie. Arch Neurol 1885;9:19-42;158-200.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Press, 1995.
4. Kurlan R. Diagnostic criteria for genetic studies of Tourette syndrome. Arch Neurol 1997;54:517-8.
5. Freeman RD, Fast DK, Kent M. DSM-IV criteria for Tourette's. J Am Acad Child Adolesc Psychiatry 1995;34:400-1.
6. Comings DE. DSM-IV criteria for Tourette's. J Am Acad Child Adolesc Psychiatry 1995;34:401-2.
7. Erenberg G. Tourette syndrome [letter]. Arch Neurol 1996;53:588.
8. Shapiro AK, Shapiro ES. An update of Tourette syndrome. Am J Psychother 1982;36:379-90.
9. Bruun RD, Budman CL. The natural history of Gilles de la Tourette's syndrome. In: Kurlan R, editor. Handbook on Tourette's syndrome and related tic disorders. New York: Marcel Dekker, 1993.
10. Lees AJ, Robertson M, Trimble MR, Murray NM. A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry 1984;47:1-8.
11. Micheli F, Gatto M, Gershanik O, Steinschnaider A. Gilles de la Tourette syndrome: Clinical features of 75 cases from Argentina. Behav Neurol 1995;8:75-80.
12. Bruun RD, Budman CL. The course and prognosis of Tourette syndrome. In: Jankovic J, editor. Neurologic clinics: Tourette syndrome. Philadelphia: WB Saunders, 1997:291-8.
13. Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: A follow-up study. Ann Neurol 1987;22:383-5.
14. Bruun RD. The natural history of Tourette's syndrome. In: Cohen DJ, Bruun RD, Leckman, editors. Tourette's syndrome and tic disorders: Clinical understanding and treatment. New York: John Wiley & Sons, 1988:21-39.
15. Sandor P, Musisi S, Moldofosky H, Lang A. Gilles de la Tourette's syndrome: A follow-up study. J Clin Psychopharmacol 1990;3:197-9.
16. Shapiro ES, Shapiro EK. Gilles de la Tourette syndrome and tic disorders. Harvard Medical School Mental Health Letter, May 1989:5.
17. Wojcieszek J, Feigin A, Kurlan R. Worsening of tics in an elderly woman with Tourette's syndrome [abstract]. Mov Disord 1995;10: 702.
18. Kurlan R, Behr J, Medved L, Shoulson I, Pauls D, Kidd JR, et al. Familial Tourette's syndrome: Report of a large pedigree and potential for linkage analysis. Neurology 1986;36:772-6.
19. Erenberg G, Cruse RP, Rothner AD. Tourette syndrome: An analysis of 200 pediatric and adolescent cases. Cleve Clin Q 1986;53:127-31.
20. McMahon WM, Leppert M, Filoux F, van de Wetering, Hasstedt S. Tourette symptoms in 161 related family members. Adv Neurol 1992;58:159-65.
21. Goldenberg JN, Brown SB, Weiner WJ. Coprolalia in younger patients with Gilles de la Tourette syndrome. Mov Disord 1994;9: 622-5.
22. Cohen AJ, Leckman JF. Sensory phenomena associated with Gilles de la Tourette's syndrome. J Clin Psychiatry 1992;53:319-23.
23. Leckman JF, Pauls DL, Peterson BS, Riddle MA, Anderson GM, Cohen DJ. Pathogenesis of Tourette syndrome. In: Chase T, Friedhoff A, Cohen DJ, editors. Tourette's syndrome: Advances in neurology. Vol 58. New York: Raven Press, 1992:15-24.
24. Kurlan R, Lichter D, Hewitt D. Sensory tics in Tourette's syndrome. Neurology 1989;39:731-4.
25. Karp BI, Hallett M. Extracorporeal 'phantom' tics in Tourette's syndrome. Neurology 1996;46:38-40.
26. Jankovic J. Phenomenology and classification of tics. In: Jankovic J, editor. Neurologic clinics: Tourette syndrome. Philadelphia: WB Saunders, 1997:267-75.
27. Kurlan RM. Tourette's syndrome. In: Watts RL, Koller WC, editors. Movement disorders: Neurologic principles and practice. New York: McGraw-Hill, 1997:569-75.
28. Scahill LD, Leckman JF, Marek KL. Sensory phenomena in Tourette's syndrome. Adv Neurol 1995;65:273-80.
29. Kurlan R. Tourette's syndrome: Current concepts. Neurology 1989;39:1625-30.
30. Singer HS, Rosenberg LA. Development of behavioral and emotional problems in Tourette's syndrome. Pediatr Neurol 1989;5:41-4.
31. Grad LR, Pelcovitz D, Olson M, Matthews M, Grad GJ. Obsessive-compulsive symptomatology in children with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1987;26:69-73.
32. Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette's syndrome. Can J Neurol Sci 1987;14:541-6.
33. Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder with hyperactivity: Are they generally related? J Am Acad Child Psychiatry 1984;23:138-46.
34. Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987;41:701-41.
35. Frankel M, Cummings JL, Robertson MM, Trimble MR, Hill MA, Benson DF. Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology 1986;36:378-82.
36. Pauls DL, Towbin KE, Leckman JF, Zahner GEP, Cohen DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder: Evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986;43:1180-2.
37. Como PG. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 1995;65:281-91.
38. Coffey BJ, Park KS. Behavioral and emotional aspects of Tourette syndrome. In: Jankovic J, editor. Neurologic clinics: Tourette syndrome. Philadelphia: WB Saunders, 1997:277-89.
39. Burd L, Kerbeshian J, Wikenheiser M, Fisher W. A prevalence study of Gilles de la Tourette syndrome in North Dakota school-age children. J Am Acad Child Psychol 1986;25:552-3.
40. Caine ED, McBride MD, Chiverton P, Bamford KA, Rediess S, Shiao J. Tourette's syndrome in Monroe County school children. Neurology 1988;38:472-5.
41. Nomoto F, Machiyama Y. An epidemiological study of tics. Jpn J Psychiatry Neurol 1990;44:649-55.
42. Apter A, Pauls DL, Bleich A, Zohar AH, Kron S, Ratzoni G, et al. An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psychiatry 1993;50:734-8.
43. Kurlan R, Whitmore D, Irvine C, McDermott MP, Como PG. Tourette's syndrome in a special education population: A pilot study involving a single school district. Neurology 1994;44:699-702.
44. Comings DE, Himes JA, Comings BG. An epidemiologic study of Tourette's syndrome in a single school district. J Clin Psychiatry 1990;51:463-9.
45. Eapen V, Robertson MM, Zeitlin H, Kurlan R. Gilles de la Tourette's syndrome in special education schools: A United Kingdom study. J Neurol 1997;244:378-82.
46. Tanner CM, Goldman SM. Epidemiology of Tourette syndrome. In: Jankovic J, editor. Neurologic clinics: Tourette syndrome. Philadelphia: WB Saunders, 1997:395-402.
47. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: Evidence for autosomal dominant transmission. N Engl J Med 1986;315:993-7.
48. Baron M, Shapiro E, Shapiro A, Rainer JD. Genetic analysis of Tourette syndrome suggesting a major gene effect. Am J Hum Genet 1981;33:767-75.
49. Price RA, Pauls, DL, Kruger SD, Caine ED. Family data support a dominant major gene for Tourette syndrome. Psychiatry Res 1987; 24:251-61.
50. Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. Gilles de la Tourette's syndrome and obsessive compulsive disorder: Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43:1180-2.
51. Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985;42:815-20.
52. Leckman JF, Price RA, Walkup JT, Ort S, Pauls DL, Cohen DJ. Birthweights of monozygotic twins discordant for Tourette's syndrome [letter]. Arch Gen Psychiatry 1987;44:100.
53. Pauls DL. Issues in genetic linkage studies of Tourette syndrome: Phenotypic spectrum and genetic model parameters. Adv Neurol 1992;58:151-7.
54. Eapen V, Pauls DL, Robertson MM. Evidence for autosomal dominant transmission in Gilles de la Tourette syndrome: United Kingdom Cohort Study. Br J Psychiatry 1993;162:593-6.
55. Kurlan R, Eapen V, Stern J, McDermott MP, Robertson MM. Bilineal transmission in Tourette's syndrome families. Neurology 1994;44:2336-42.
56. Lichter DG, Jackson LA, Schachter M. Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 1995;45:924-8.
57. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. N Engl J Med 1986;315:993-7.
58. Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E, et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993;43:950-6.
59. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997;49:410-5.
60. Hynd GW, Hern KL, Novey ES, Eliopulos D, Marshall R, Gonzalez JJ, et al. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339-47.
61. Chase TN, Geoffrey V, Gillespie GM, Burrows GH. Structural and functional studies of Gilles de la Tourette syndrome. Rev Neurol (Paris) 1986;142:851-5.
62. Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J, et al. The functional neuroanatomy of Tourette's syndrome: An FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 1993;9:277-91.
63. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C, et al. The metabolic anatomy of Tourette's syndrome. Neurology 1997;48:927-34.
64. Comings DE, Himes JA, Comings BG. An epidemiologic study of Tourette's syndrome in a single school district. J Clin Psychiatry 1990;51:463-9.
65. Klawans H, Falk DK, Nausieda PA, Weiner WJ. Gilles de la Tourette's syndrome after long-term chlorpromazine therapy. Neurology 1978;28:1064-8.
66. Karagianis JL, Nagpurkar R. A case of Tourette syndrome developing during haloperidol treatment. Can J Psychiatry 1990;35:228-32.
67. Erenberg G, Lederman RJ. Naltrezone in the treatment of Tourette's syndrome. Neurology 1985;135:1346-8.
68. Turjanski N, Sawle GV, Playford ED, Weeks R, Lammerstma AA, Lees AJ, et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry 1994;57:688-92.
69. 123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 1995;152:1359-61.
70. Price RA, Leckman JF, Pauls DL, Cohen DJ, Kidd KK. Gilles de la Tourette syndrome: Tics and central nervous system stimulants in twins and non-twins. Neurology 1986;36:232-7.
71. Singer HS, Butler IJ, Tune LE, Seifert WE Jr, Coyle JT. Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 1982;12: 361-6.
72. Buder IJ, Koslow SH, Seifert WE Jr, Caprioli RM, Singer HS. Biogenic amine metabolism in Tourette syndrome. Ann Neurol 1979;6: 37-9.
73. Haber SN, Kowall NW, Vonsattel JP, Bird ED, Richardson EP Jr. Gilles de la Tourette's syndrome: A postmortem neuropathological and immunohistochemical study. J Neurol Sci 1986;75:225-41.
74. Packer LE. Social and educational resources for patients with Tourette syndrome. In: Jankovic J, editor. Neurologic clinics: Tourette syndrome. Philadelphia: WB Saunders, 1997:457-71.
75. Goetz CG, Tanner CM, Klawans HL. Fluphenazine and multifocal tic disorders. Arch Neurol 1984;41:271-2.
76. Bruun RD, Budman CL. Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1996;57:29-31.
77. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias. Neurology 1988;3:391-4.
78. Kurlan R. Treatment of tics. In: Jankovic J, editor. Neurologic clinics: Tourette syndrome. Philadelphia: WB Saunders, 1997:403-9.
79. Cohen DJ, Detlor J, Young JG, Shaywitz BA. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980;37: 1350-7.
80. Shapiro AK, Shapiro E, Eisenkraft GJ. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. Arch Gen Psychiatry 1983;40:1235-40.
81. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991;48:324-8.
82. Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM. Clonidine and Gilles de la Tourette's syndrome: Double-blind study using objective rating methods. Ann Neurol 1987;21:307-10.
83. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord 1994;9:347-9.
84. Scott BL, Jankovic J, Donovan DT. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome. Mov Disord 1996;11:431-3.
85. Stevenson RD, Wolraich MI. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Clin Pharmacol 1989;36:1183-95.
86. Green WH. The treatment of attention-deficit hyperactivity disorder with nonstimulant medications [letter]. Child Adolesc Psychiatr Clin North Am 1995;4:169.
87. Gadow KD, Sverd J. Stimulants for ADHD in child patients with Tourette's syndrome: The issue of relative risk. J Dev Behav Pediatr 1990;11:269-71.
88. Robertson MM, Eapen V. Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome. Clin Neuropharmacol 1992;15:408-25.
89. Cohen DJ, Young JG, Nathanson JA, Shaywitz BA. Clondine in Tourette's syndrome. Lancet 1979;2:551.
90. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993;32:350-3.
91. Jankovic J. Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol 1993;50:286-8.
92. Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, et al. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 1996;46:965-8.
93. Como PG, Kurlan R. An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome. Neurology 1991;41:872-4.
94. Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropharmacol 1993;16:167-72.
95. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory OCD: A double-blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302-8.
96. Kurlan R, Kersun J, Ballentine HT Jr, Caine ED. Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome. Mov Disord 1990;5:152-5.
97. Robertson M, Doran M, Trimble M, Lees AJ. The treatment of Gilles de la Tourette syndrome by limbic leucotomy. J Neurol Neurosurg Psychiatry 1990;53:691-4.
98. Baer L, Rauch SL, Ballantine T Jr, Martuza R, Cosgrove R, Cassem E, et al. Cingulotomy for intractable obsessive-compulsive disorder: Prospective long-term follow-up of 18 patients. Arch Gen Psychiatry 1995;52:384-92.
99. Gerlach J. New antipsychotics: Classification, efficacy, and adverse effects. Shizophr Bull 1991;17:289-309.
100. Beasley CM, Tollefson G, Tran P, Tollefson G, Tran P, Hamilton S. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996;14:111-23.
101. Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience. J Am Child Adolesc Psychiatry 1995;34:1140-6.
102. Arnsten AFT, Steere JC, Hunt RD. The contribution of alpha-2-adrenergic mechanisms to prefrontal conical cognitive function: Potential significance to attention deficit disorder. Arch Gen Psychiatry 1996;53:448-55.
103. Albin R, Young A, Penney J. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-75.
104. Crossman AR, Sambrook MA, Jackson SA. Experimental hemichorea/ballismus in the monkey: Studies of the intracerebral site of action in a drug-induced dyskinesia. Brain 1984;107:579-96.
105. Page RD, Sambrook MA, Crossman AR. Thalamotomy for the alleviation of levodopa-induced dyskinesia: Experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treated parkinsonian monkey. Neuroscience 1993;55:147-65.